Reduction of Cortical Bone Turnover and Erosion Depth After 2 and 3 Years of Denosumab: Iliac Bone Histomorphometry in the FREEDOM Trial

Tekijä Chavassieux, Pascale, Portero‐Muzy, Nathalie, Roux, Jean Paul, Horlait, Stéphane, Dempster, David W, Wang, Andrea, Wagman, Rachel B, Chapurlat, Roland
Julkaisussa J Bone Miner Res (2019)

Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis‡

Tekijä Xue, Fei, Ma, Haijun, Stehman-Breen, Catherine, Haller, Christine, Katz, Leonid, Wagman, Rachel B, Critchlow, Cathy W, Denosumab Global Safety Assessment Team
Julkaisussa Pharmacoepidemiol Drug Saf (2013)

Effects of Long-Term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis

Tekijä Dempster, David W, Brown, Jacques P, Fahrleitner-Pammer, Astrid, Kendler, David, Rizzo, Sebastien, Valter, Ivo, Wagman, Rachel B, Yin, Xiang, Yue, Susan V, Boivin, Georges
Julkaisussa J Clin Endocrinol Metab (2018)

Discontinuation of Denosumab and Associated Fracture Incidence: Analysis From the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial

Tekijä Brown, Jacques P, Roux, Christian, Törring, Ove, Ho, Pei-Ran, Beck Jensen, Jens-Erik, Gilchrist, Nigel, Recknor, Christopher, Austin, Matt, Wang, Andrea, Grauer, Andreas, Wagman, Rachel B
Julkaistu 2013

Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study

Tekijä Adachi, Jonathan D., Bone, Henry G., Daizadeh, Nadia S., Dakin, Paula, Papapoulos, Socrates, Hadji, Peyman, Recknor, Chris, Bolognese, Michael A., Wang, Andrea, Lin, Celia J. F., Wagman, Rachel B., Ferrari, Serge
Julkaisussa BMC Musculoskelet Disord (2017)

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy

Tekijä Al-Hendy, Ayman, Lukes, Andrea S., Poindexter, Alfred N., Venturella, Roberta, Villarroel, Claudio, Critchley, Hilary O.D., Li, Yulan, McKain, Laura, Arjona Ferreira, Juan C., Langenberg, Andria G.M., Wagman, Rachel B., Stewart, Elizabeth A.
Julkaisussa N Engl J Med (2021)

The Effect of Three or Six Years of Denosumab Exposure in Women With Postmenopausal Osteoporosis: Results From the FREEDOM Extension

Tekijä Bone, Henry G., Chapurlat, Roland, Brandi, Maria-Luisa, Brown, Jacques P., Czerwiński, Edward, Krieg, Marc-Antoine, Mellström, Dan, Radominski, Sebastião C., Reginster, Jean-Yves, Resch, Heinrich, Ivorra, Jose A. Román, Roux, Christian, Vittinghoff, Eric, Daizadeh, Nadia S., Wang, Andrea, Bradley, Michelle N., Franchimont, Nathalie, Geller, Michelle L., Wagman, Rachel B., Cummings, Steven R., Papapoulos, Socrates
Julkaistu 2013